Early detection and accurate diagnosis of Alzheimer’s disease (AD) provides the opportunity to intervene early in the disease process before serious cognitive impairment occurs. Although currently approved therapies only treat symptoms of AD and are not curative, in many patients they do slow the disease process, delaying the development of severe dementia and prolonging functionality. With the advent of disease-modifying therapies, early diagnosis may become even more crucial. This program reviews important aspects of the burden of AD, its diagnosis and treatment, promising therapies for the future, and valuable resources for both patient and clinician. An illustrative case demonstrates real-world practical applications.
eNewsletter with interactive benchmarking and audio commentary
To educate NPs and PAs on the early detection and diagnosis of AD, its treatment, resources for clinicians and patients, and promising new therapies currently under investigation.
After completing this activity, participants should be better able to:
- Detect cognitive changes and perform a differential diagnosis in patients presenting with cognitive complaints
- Describe the new Centers for Medicare and Medicaid Services code for the reimbursement of cognitive assessment
- Initiate and maintain pharmacologic treatment in patients with AD to slow symptomatic decline and monitor over time
- Discuss with patients and caregivers community resources, clinical trials, registries, and other support services as part of a comprehensive care plan
NPs and PAs
CNE Credit Designation Statement
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing contact hours: 1.00, which includes 0.25 hours of pharmacology credit
Nurse Planner: Mary Knudtson, DNSc, NP, FAAN
PA Planner: Daniel Thibodeau, MHP, PA-C
AAPA Credit Designation Statement
Continuing Education Alliance has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until December 28, 2019. PAs should only claim credit commensurate with the extent of their participation.
This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity is supported by an educational grant from Allergan, Inc. and Biogen MA, Inc.
Practicing Clinicians Exchange gratefully acknowledges Miller Medical Communications, LLC, for their contributions as educational partner for this activity.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, Miller Medical Communications, LLC., or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Galvin: consultant: Biogen, Bracket, Eisai, Medivante.
The Planning Committee for this activity included Mary Knudtson, DNSc, NP, FAAN, of the University of California, Santa Cruz; Dan Thibodeau, MPH, PA-C, of Eastern Virginia Medical School; Ruth Cohen and Warren Beckman of Continuing Education Alliance; and Lyerka Miller, PhD, CCMP, of Miller Medical Communications, LLC. The members of the Planning Committee have no relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: December 28, 2018
Expiration date: December 28, 2019
© 2019 Practicing Clinicians Exchange. All Rights Reserved. BGPCE94618